Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

CAS 22009-38-7 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 22009-38-7
Also known as: 22009-38-7, 7-hydroxy-3,4-dihydronaphthalen-1(2h)-one, 7-hydroxy-3,4-dihydro-2h-naphthalen-1-one, 7-hydroxy-3,4-dihydro-1(2h)-naphthalenone, 1(2h)-naphthalenone, 3,4-dihydro-7-hydroxy-, Mfcd01312225
Molecular Formula
C10H10O2
Molecular Weight
162.18  g/mol
InChI Key
LGFSAJZSDNYVCW-UHFFFAOYSA-N

1 2D Structure

CAS 22009-38-7

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
7-hydroxy-3,4-dihydro-2H-naphthalen-1-one
2.1.2 InChI
InChI=1S/C10H10O2/c11-8-5-4-7-2-1-3-10(12)9(7)6-8/h4-6,11H,1-3H2
2.1.3 InChI Key
LGFSAJZSDNYVCW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC2=C(C=C(C=C2)O)C(=O)C1
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 22009-38-7

2. 7-hydroxy-3,4-dihydronaphthalen-1(2h)-one

3. 7-hydroxy-3,4-dihydro-2h-naphthalen-1-one

4. 7-hydroxy-3,4-dihydro-1(2h)-naphthalenone

5. 1(2h)-naphthalenone, 3,4-dihydro-7-hydroxy-

6. Mfcd01312225

7. 7-hydroxytetralin-1-one

8. 7-hydroxytetralone

9. 7-hydroxy-tetralone

10. 7-hydroxy-1-tetralone (5)

11. Schembl385554

12. Dtxsid00341263

13. Bdbm166645

14. Amy14181

15. Bcp16590

16. Zinc24627693

17. Akos006229303

18. Cs-w022544

19. Mb01768

20. Ac-27437

21. As-10078

22. Sy045775

23. 3,4-dihydro-7-hydroxy-1(2h)-naphthalenone

24. Bb 0257319

25. Ft-0648907

26. H1650

27. 7-hydroxy-3,4-dihydro-1(2h)-naphthalenone #

28. En300-191143

29. A851740

30. 7-hydroxy-1,2,3,4-tetrahydronaphthalen-1-one

31. Z1198156579

2.3 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 162.18 g/mol
Molecular Formula C10H10O2
XLogP31.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count0
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area37.3
Heavy Atom Count12
Formal Charge0
Complexity188
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag France
Digital Content Digital Content
50890-96-5
Velpatasvir
PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, ...
PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, active pharmaceutical ingredients and functional excipients for pharmaceutical and personal care companies worldwide. Its business includes research, product and process development, pilot-scale, industrial production and regulatory approvals support. It adds value to its clients' intellectual property through constant innovation in manufacturing techniques throughout the product life cycle. PMC Isochem's facilities are located within 60 miles of Paris and are all US FDA-audited plants.
Flag France
Digital Content Digital Content
74761-42-5
Velpatasvir
PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, ...
PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, active pharmaceutical ingredients and functional excipients for pharmaceutical and personal care companies worldwide. Its business includes research, product and process development, pilot-scale, industrial production and regulatory approvals support. It adds value to its clients' intellectual property through constant innovation in manufacturing techniques throughout the product life cycle. PMC Isochem's facilities are located within 60 miles of Paris and are all US FDA-audited plants.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY